Qualitas Funds' News

Return to Qualitas Funds news
  • Portfolio transactions

Qualitas Funds Direct II– Acquisition of Develco Pharma

We are delighted to announce that Develco Pharma has been added to the Qualitas Funds Direct II portfolio. This transaction was led by one of our managers located in Germany.

Develco Pharma is a specialty pharmaceutical company that develops and produces innovative formulations for drugs with known active ingredients. After approval, the products are licensed out to internationally operating pharmaceutical companies. Develco Pharma is responsible for the entire value chain, from development and approval, to manufacture and delivery. By focusing on extended or modified releases, the company has grown into an internationally recognized and renowned provider.

Qualitas Funds
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.